Straits Times Index
3,426.47 -3.98 (-0.12%) Nikkei
37,667.41 -202.10 (-0.53%) Hang Seng
17,021.31 +16.34 (+0.10%) FTSE 100
8,285.71 +99.36 (+1.21%) Bitcoin USD
67,785.20 +1,093.76 (+1.64%) CMC Crypto 200
1,369.11 +38.50 (+2.89%)
Jazz Pharmaceuticals plc (JAZZ)
After hours:
| Previous close | 109.54 |
| Open | 110.00 |
| Bid | 111.55 x 100 |
| Ask | 111.65 x 100 |
| Day's range | 109.32 - 112.88 |
| 52-week range | 99.06 - 146.70 |
| Volume | |
| Avg. volume | 765,569 |
| Market cap | 7.036B |
| Beta (5Y monthly) | 0.58 |
| PE ratio (TTM) | 23.10 |
| EPS (TTM) | 4.83 |
| Earnings date | 31 Jul 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 178.56 |
PR NewswireJazz Pharmaceuticals Shareholders Elect Laura Hamill to the Company's Board of Directors at Annual General Meeting
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced the election of a new independent director, Laura Hamill, to its Board of Directors. Ms. Hamill, a 35-year veteran of the pharmaceutical industry brings broad executive leadership and global commercial operations expertise to the company's Board. Ms. Hamill's election follows the appointment of Patrick Kennedy earlier this year and reflects Jazz's continued focus on Board renewal. At the Annual General meeting held today, shareholders not o
ZacksNeurocrine Biosciences (NBIX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Neurocrine (NBIX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
ZacksJazz Pharmaceuticals (JAZZ) Reports Next Week: Wall Street Expects Earnings Growth
Jazz (JAZZ) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
